Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-25 @ 7:00 PM
NCT ID: NCT05067504
Description: SP. The investigator reported AEs systematically at each visit.
Frequency Threshold: 5
Time Frame: From first treatment on Day 1 up to the end of study on Day 180 (an average of 6 months)
Study: NCT05067504
Study Brief: Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and Neck
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Stage 1: Octave-Ultherapy Treatment Subjects received a single Octave-Ultherapy treatment of the brow, face, and neck on Day 1 of Stage 1 with two transducers. 0 None 0 10 5 10 View
Stage 2: Octave-Ultherapy Treatment Subjects received a single Octave-Ultherapy treatment of the brow, face, and neck on Day 1 of Stage 2 with up to four transducers. 0 None 1 40 5 40 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Follicular lymphoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 25.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Application site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Application site pruritus SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Application site urticaria SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Application site discomfort SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Application site dysaesthesia SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.1 View
Diverticulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View